NNNima Naghshtabrizi

Nima Naghshtabrizi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nima Naghshtabrizi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Caden Ngeow

    Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

    2 shared publications
  • Dequan Lou

    University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, Pennsylvania, USA

    2 shared publications
  • Keven Mara Robinson

    Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

    2 shared publications
  • Kong Chen

    Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    2 shared publications
  • Radha Gopal

    Department of Pediatrics, University of Pittsburgh, PA, United States

    2 shared publications
  • Ravineel B. Singh

    Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

    2 shared publications

Latest Publications

  • Open Access

    Broad remodeling of the pulmonary immune landscape occurs during IAPA with specific functional deficits of neutrophil subsets

    by Nima Naghshtabrizi, Dequan Lou, Yonne Karoline Tenório de Menezes, Ravineel B. Singh, Shuxia Wang, Caden Ngeow, Fan Li, Radha Gopal, Kong Chen, Keven Robinson

    Background: Influenza-associated pulmonary aspergillosis (IAPA) is a severe complication of influenza infection associated with prolonged intensive care unit stay and increased mortality. Although impaired antifungal immunity has been implicated in IAPA pathogenesis, the cell type-specific immune mechanisms driving susceptibility remain incompletely understood. We aimed to characterize the pulmonary immune landscape during IAPA using single-cell transcriptomics and functional neutrophil assays. Methods: Male C57BL/6 mice were assigned to naïve control, influenza A/PR/8/34 (H1N1) infection, A. fumigatus (ATCC 42202) infection, or IAPA groups. Lung CD45 + immune cells underwent single-cell RNA sequencing with downstream clustering and CellChat ligand-receptor interaction analysis. Differential gene expression analyses were performed across myeloid, lymphoid, and neutrophil populations. Functional neutrophil responses were evaluated using flow cytometry, myeloperoxidase activity assays, and FLARE (fluorescent Aspergillus reporter) conidia to assess fungal conidia uptake and killing. Cross-species validation was performed using gene set enrichment analysis compared with published human IAPA transcriptomic datasets. Results: IAPA broadly remodeled the pulmonary immune landscape across myeloid, lymphoid, and neutrophil compartments. Myeloid cells showed coordinated suppression of fungal pattern recognition receptors, lysosomal biogenesis programs, and inflammatory signaling. Lymphoid populations exhibited transcriptional signatures of T cell exhaustion and Th17 suppression. Within the neutrophil compartment, we identified two transcriptionally and functionally distinct populations, conventional and inflammatory neutrophils, with divergent antifungal effector capacities. Inflammatory neutrophils showed selective killing defects, while both subsets exhibited impaired phagocytic uptake during IAPA. Murine transcriptomic findings demonstrated strong concordance with immune dysfunction signatures identified in human IAPA. Conclusion: IAPA susceptibility arises from coordinated transcriptional dysfunction spanning innate and adaptive immune compartments. Distinct neutrophil subset dysfunction, impaired fungal recognition pathways, and T-cell exhaustion signatures collectively contribute to defective fungal clearance, providing mechanistic insight into IAPA susceptibility and potential therapeutic targets.

  • Open Access

    IL-27 Signaling Protects Against Influenza-Associated Pulmonary Aspergillosis Through Inhibition of Type 2 Immunity and Enhanced Antifungal Immunity

    by Nima Naghshtabrizi, Yonne Karoline Tenório de Menezes, Shuxia Wang, Ravineel B. Singh, Dequan Lou, Kong Chen, Radha Gopal, Caden Ngeow, Keven M. Robinson

    Influenza-associated pulmonary aspergillosis (IAPA) is a severe complication of influenza infection associated with substantial mortality. Influenza disrupts pulmonary host defenses and alters innate immune responses, predisposing patients to invasive fungal infection. Interleukin-27 (IL-27) is an immunoregulatory cytokine with context-dependent antiviral and antifungal effects; however, its role during IAPA remains undefined. A mouse model of IAPA was established by infecting wild-type and IL-27 receptor α-deficient ( Il27ra − / − ) mice with influenza A, followed by Aspergillus fumigatus challenge. IL-27 and IL-27Rα expression were increased during IAPA. Single-cell RNA sequencing identified monocytes as the primary source of IL-27 and T cells as major IL-27rα-expressing cells. Il27ra − / − mice exhibited significantly increased pulmonary fungal and influenza viral burden, enhanced type 2 immune responses characterized by elevated IL-4, IL-5, IL-9, IL-13, eosinophils, Th2 cells, pathogenic Th2 cells, and ILC2s. Despite increased eosinophil abundance, eosinophil-mediated conidial killing was impaired in Il27ra − / − mice. IL-27Rα deficiency also reduced macrophage abundance and impaired macrophage conidial uptake. Conversely, timed administration of rIL-27 enhanced fungal clearance, improved survival, and increased macrophage conidial uptake and augmented eosinophil killing capacity during IAPA. IL-27 signaling is a protective immunoregulatory cytokine during IAPA that limits pathological type 2 inflammation and enhances antifungal effector function of both eosinophils and macrophages. These findings identify IL-27 as a potential therapeutic in IAPA.